NCT06794268
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- CIBMTR Milwaukee, Wisconsin, United States
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
9,972 public trials
2,027 recruiting studies
Immunoproliferative Disorders trial results
NCT06839898
- Conditions
- Astigmatism, Eye Diseases, Hemic and Lymphatic Diseases, +14 more
- Locations
-
- Precise Vision Augentagesklinik Greven Münster, North Rhine-Westphalia, Germany
- Precise Vision Augentagesklinik Rheine Rheine, North Rhine-Westphalia, Germany
- Precise Vision Augentagesklinik Rheine Steinfurt, North Rhine-Westphalia, Germany
- Netradhama Superspeciality Eye Hospital Bangalore, Karnataka, India
NCT06151080
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Follicular Lymphoma, +12 more
- Locations
-
- Bing Xu Xiamen, Fujian, China
NCT06158412
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Bing Xu Xiamen, Fujian, China
Recruiting
Chidamide Combined With Linperlisibon for the Treatment of Refractory/Relapsed Follicular Lymphoma
NCT06158386
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Bing Xu Xiamen, Fujian, China
NCT06834529
- Conditions
- Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +16 more
- Locations
-
- the Fifth Medical Center of Chinese People's Liberation Army General Hospital Beijing, Beijing Municipality, China
Recruiting
Chidamide and Duvalisibon for the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma
NCT06151106
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
- Locations
-
- The First Affiliated Hosptial of Xiamen University Xiamen, Fujian, China
Recruiting
Exercise During Chemotherapy Treatment As Adjuvant Program in Patients with Lymphoma: EDONOLA Study.
NCT06660446
- Conditions
- Behavior, Fatigue, Hemic and Lymphatic Diseases, +10 more
- Locations
-
- Hospital Universitario Araba (HUA) Vitoria - Gateiz, Araba, Spain
- Hospital Universitario Galdakao (HUG) Galdakao, Bizkaia, Spain
- Hospital Universitario Donostia (HUD) San Sebastián, Guipuzcoa, Spain
NCT06559345
- Conditions
- Acute Lymphoblastic Leukemia, Pediatric, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
NCT06564545
- Conditions
- Acute Lymphoblastic Leukemia, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China